EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Alzheimer’s Disease Brain, Its Microvasculature, and NADPH Oxidase

Mortimer Mamelak

Journal of Alzheimer's Disease · 22.04.2024 · 99 (s1) · S109-S118

DOI: 10.3233/jad-230415 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 22.04.2024. Verfasst von Mortimer Mamelak. Beteiligte Einrichtung: Department of Psychiatry, Baycrest Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, NADPH Oxidases, Brain, Microvessels. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The deterioration of the brain’s microvasculature, particularly in the hippocampus, appears to be a very early event in the development of Alzheimer’s disease (AD), preceding even the deposition of amyloid-β. A damaged microvasculature reduces the supply of oxygen and glucose to this region and limits the production of energy, ATP. The damage may be a function of the rise with age in the expression and activity of NADPH oxidase (NOX) in these microvessels. This rise renders these vessels vulnerable to the effects of oxidative stress and inflammation. The rise in NOX activity with age is even more marked in the AD brain where an inverse correlation has been demonstrated between NOX activity and cognitive ability. Apocynin, a putative NOX inhibitor, has been shown to block the damaging effects of NOX activation. Apocynin acts as a strong scavenger of H2O2, and as a weak scavenger of superoxide. Like apocynin, sodium oxybate (SO) has also been shown to block the toxic effects of NOX activation. The application of SO generates NADPH and ATP. SO inhibits oxidative stress and maintains normal cerebral ATP levels under hypoxic conditions. Moreover, it acts epigenetically to attenuate the expression of NOX. SO may delay the onset and slow the progress of AD by suppling energy and maintaining an antioxidative environment in the brain throughout the night. The slow wave activity produced by SO may also activate the glymphatic system and promote the clearance of amyloid-β from the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNADPH OxidasesBrainMicrovesselsHumansAnimalsOxidative StressAcetophenones

Stichwörter der Autor:innen

Alzheimer’s diseaseNADPHNADPH oxidaseamyloid-βapocynincerebral microvasculatureoxidative stresssodium oxybate

Substanzen

NADPH OxidasesAcetophenones

Autor:innen und Institutionen

  • Department of Psychiatry, Baycrest Hospital, University of Toronto, Toronto, Ontario, Canada.

Zitieren

APA

Mamelak, M. (2024). The Alzheimer’s Disease Brain, Its Microvasculature, and NADPH Oxidase. Journal of Alzheimer's Disease, 99(s1), S109-S118. https://doi.org/10.3233/jad-230415

Vancouver

Mamelak M. The Alzheimer’s Disease Brain, Its Microvasculature, and NADPH Oxidase. Journal of Alzheimer's Disease. 2024;99(s1):S109-S118. doi:10.3233/jad-230415

BibTeX
@article{Mamelak2024,
  author = {Mamelak, Mortimer},
  title = {The Alzheimer’s Disease Brain, Its Microvasculature, and NADPH Oxidase},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  volume = {99},
  number = {s1},
  pages = {S109--S118},
  doi = {10.3233/jad-230415}
}
Kostenlos starten →